Cotrimoxazol Dosage and Usage Guidelines

Introduction to Cotrimoxazol Usage

• The American College of Physicians recommends cotrimoxazol for various infections, including urinary tract infections, with a dosage of 1 double-strength tablet (160 mg TMP/800 mg SMZ) every 12 hours for 3 days for uncomplicated cystitis 1
• The Infectious Diseases Society of America suggests that patients with HIV and CD4+ <200 cells/µL should receive prophylaxis for Pneumocystis jirovecii pneumonia (PCP) with 1 double-strength tablet daily 2

Dosage by Clinical Indication

• For urinary tract infections, the recommended dosage is 1 double-strength tablet every 12 hours for 3 days for uncomplicated cystitis, and 1 double-strength tablet every 12 hours for 14 days for pyelonephritis, if the pathogen is susceptible 1
• For skin and soft tissue infections, including MRSA, the dosage is 1-2 double-strength tablets every 12 hours for 7-10 days 1
• For maximum dosage, up to 2 double-strength tablets twice daily (320-640 mg TMP/1600-3200 mg SMZ total daily) can be used 3

Profilaxis of Pneumocystis jirovecii (PCP)

• The Centers for Disease Control and Prevention recommends initiating PCP prophylaxis in patients with HIV and CD4+ <200 cells/µL, history of oropharyngeal candidiasis, or CD4+ <14% or history of AIDS-defining illness 2
• The preferred regimen for PCP prophylaxis is 1 double-strength tablet daily 2
• An effective alternative regimen is 1 single-strength tablet daily, which may be better tolerated 2
• Another alternative is 1 double-strength tablet three times a week on consecutive days 2, 3

Treatment of Pneumocystis jirovecii Pneumonia

• The recommended dosage for treatment is 75-100 mg/kg of sulfamethoxazole and 15-20 mg/kg of trimethoprim per 24 hours, divided into equal doses every 6 hours for 14-21 days, which is equivalent to approximately 2 double-strength tablets every 6 hours for a 70 kg adult 4

Adjustment for Renal Insufficiency

• It is critical to adjust the dosage in patients with compromised renal function, with a creatinine clearance >30 mL/min requiring the standard dose, 15-30 mL/min requiring half the usual dose, and <15 mL/min requiring half the dose or consideration of an alternative agent 4
• For patients on hemodialysis, administer half the dose after each dialysis session 4

Important Safety Considerations

• The American College of Obstetricians and Gynecologists recommends avoiding cotrimoxazol in term pregnancy due to the risk of congenital defects 3, 1
• The European Medicines Agency advises against using cotrimoxazol in patients with G6PD deficiency due to the risk of hemolytic anemia 3
• The FDA recommends avoiding concomitant use with methotrexate at therapeutic doses due to the risk of severe bone marrow suppression 3

Monitoring and Management of Adverse Reactions

• The National Institutes of Health recommends obtaining a baseline hemogram and monitoring monthly to detect hematologic toxicity, particularly thrombocytopenia 3
• If a non-life-threatening adverse reaction occurs, continue treatment if clinically feasible, and consider reintroducing the medication after the event resolves 2
• Desensitization allows up to 70% of patients to tolerate reintroduction 2

Considerations of Resistance

• The World Health Organization recommends not using cotrimoxazol empirically if local E. coli resistance exceeds 20%, as patients infected with resistant strains have a >17 times higher risk of therapeutic failure 1
• Clinical cure rates fall from 88% with susceptible organisms to 41-54% with resistant strains 1

Alternatives When Cotrimoxazol is Not Appropriate

• The Infectious Diseases Society of America suggests using nitrofurantoin 100 mg every 12 hours for 5-7 days for uncomplicated cystitis (not pyelonephritis) 1
• Fluoroquinolones can be used when local resistance is <10% 1
• For PCP prophylaxis, alternatives include dapsone, dapsone plus pyrimethamine plus leucovorin, pentamidine aerosol, or atovaquone 2

Trimethoprim‑Sulfamethoxazole (Bactrim) Dosing and Alternatives for Specific Indications

Urinary Tract Infections

• Pyelonephritis: For adults with confirmed susceptibility, prescribe 1 double‑strength (DS) tablet (800 mg/160 mg) twice daily for 14 days. If susceptibility is unknown, an initial intravenous dose of a long‑acting parenteral antimicrobial (e.g., 1 g ceftriaxone) may be considered before oral therapy. 5

Pneumocystis jirovecii Pneumonia (PCP) Prophylaxis

• Primary prophylaxis based on CD4⁺ count: Give 1 DS tablet daily to patients whose CD4⁺ count is < 200 cells/µL. [6][7]
• Alternative daily regimen: Use 1 single‑strength tablet daily (better tolerated) when daily DS dosing is not tolerated. 7
• Alternative intermittent regimen: Administer 1 DS tablet three times weekly on consecutive days (e.g., Monday‑Wednesday‑Friday) as an acceptable prophylactic schedule. [6][7]
• Expanded indication: Initiate prophylaxis in patients with oropharyngeal candidiasis or unexplained fever ≥ 100 °F for ≥ 2 weeks, regardless of CD4⁺ count. 6

Desensitization for Patients with Non‑Life‑Threatening Bactrim Reactions

• Re‑introduction after mild adverse events: When a rash, fever, or similar non‑severe reaction resolves, consider re‑starting Bactrim using a graded desensitization protocol. 7
• Success rate of desensitization: Approximately 70 % of patients tolerate Bactrim after gradual dose escalation. 7
• Alternative approach: If full desensitization is not feasible, a reduced dose or less frequent dosing schedule may be attempted. 7

Alternative Agents When Bactrim Cannot Be Used for PCP Prophylaxis

All alternative regimens are endorsed by the CDC’s MMWR recommendations. [6][7]